Wednesday, September 28, 2022
Home Blog

Snoop Dogg Is Launching His Own Line Of Breakfast Food

0
Snoop Dogg Is Launching His Own Line Of Breakfast Food
#image_title

Following his recent announcement of Snoop Loopz cereal, Calvin “Snoop Dogg” Broadus has launched his Momma Snoop Breakfast Foods line, he shared Thursday (Sept. 22).

His latest food endeavor will provide breakfast items including grits, oatmeal, maple syrup and pancake mix inspired by his mom.

“Top of the morning,” Snoop began as he introduced the products in an Instagram video captioned, “There was a void for our culture when they took Aunt Jemima off the shelves. We’re replacing it with Momma Snoop pancake mix, syrup, grits and oatmeal, adding diversity into the grocery stores industry and creating opportunities for minority-owned food products and brands.”

Momma Snoop Breakfast foods and his Snoop Loopz cereal are manufactured by the 50-year-old’s Broadus Foods company. To no surprise, serial entrepreneur Master P serves as the company’s CEO. The goal of Broadus Foods is to “inspire economic empowerment.” The company also aims to support charities, such as Door of Hope.

Snoop’s IG post also included a statement from Master P.

“Our mission is to build economic empowerment and generational wealth. The more we make, the more we give.”

The Long Beach-bred rapper revealed his Momma Snoop brand following his partnership with Funko for “Tha Dogg House” store, opening in 2023. The store will be located in Inglewood, Calif.

Check out Snoop Dogg’s announcement below.

Read More

Ukraine ports have shipped around 4.7 mln tonnes of food under grain deal

0
Ukraine ports have shipped around 4.7 mln tonnes of food under grain deal
#image_title

KYIV, Sept 24 (Reuters) – A total of 211 ships with 4.7 million tonnes of agricultural products on board have left Ukraine so far under a deal brokered by the United Nations and Turkey to unblock Ukrainian sea ports, the Ukrainian infrastructure ministry said on Saturday.

The ministry said eight ships with 131,300 tonnes of agricultural products are due to leave Ukrainian Black Sea ports on Saturday.

Ukraine’s grain exports slumped after Russia invaded the country on Feb. 24 and blockaded its Black Sea ports, driving up global food prices and prompting fears of shortages in Africa and the Middle East.

Ukraine, a global major grain producer and exporter, shipped up to 6 million tonnes of grain per month before the war.

Three Black Sea ports were reopened under a deal signed on July 22 by Moscow and Kyiv and the ministry has said these ports are able to load and send abroad 100-150 cargo ships per month.

Register now for FREE unlimited access to Reuters.com

Reporting by Pavel Polityuk. Editing by Jane Merriman

Our Standards: The Thomson Reuters Trust Principles.

Read More

Universities offer resources to help with safe at-home food preservation

0
Universities offer resources to help with safe at-home food preservation
#image_title

With the beginning of fall yesterday, people will be collecting the rest of their gardens’ fruits and vegetables for canning. The benefits of home food preservation include building a reserve of dehydrated and canned food to eat during the winter and that will stay safe during a power outage.

However, home food preservation is not without risk. One of the greatest risks of improper canning is botulism, a potentially deadly illness.

The National Center for Home Food Preservation is a great resource for current research-based recommendations for most methods of home food preservation. Their website provides detailed instructions on how to can, freeze, dry, cure and smoke, ferment, pickle, make jam and jelly and more.

The Center was established with funding from the Cooperative State Research, Education and Extension Service, U.S. Department of Agriculture (CSREES-USDA) to address food safety concerns for those who practice and teach home food preservation and processing methods.

If you haven’t done home canning before or it has been a while since you last canned food the National Center for Home Food Preservation is a great place to start learning how to do it safely. Their website can be found here.

University Extension Services
Many universities have extension services that offer classes and videos that help teach proper food preservation. Those universities include:

  • University of Minnesota Extension — Home canning basics
  • NC State Extension — General Canning
  • North Dakota State University — Canning
  • Utah State University Extension — Canning Resources
  • West Virginia University Extension — Canning

Check with your local colleges and universities to see what they have to offer. Many have free materials and courses.

About the National Center for Home Food Preservation
The Center was established with funding from the Cooperative State Research, Education and Extension Service, U.S. Department of Agriculture (CSREES-USDA) in 2000 as a multi-institutional effort with The University of Georgia and Alabama A&M University as the primary institutions. to address food safety concerns for those who practice and teach home food preservation and processing methods.

(To sign up for a free subscription to Food Safety News, click here.)

Read More

Salad products recalled across Canada over contamination from plastic pieces

0
Salad products recalled across Canada over contamination from plastic pieces
#image_title

Vegpro International Inc. is recalling various brands of salad products because of pieces of plastic in the product.

According to the Canadian Food Inspection Agency (CFIA), the recalled products were distributed in Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Canada.

Brand Product Size UPC Codes
Compliments Baby Arugula 142 g 0 68820 12596 9 BEST BEFORE:2022 SE 082022 SE 112022 SE 132022 SE 15
Compliments Baby Spinach 142 g 0 68820 12597 6 BEST BEFORE:2022 SE 062022 SE 15
Compliments Spring Mix 142 g 0 68820 12598 3 BEST BEFORE:2022 SE 062022 SE 082022 SE 132022 SE 14
Fresh Attitude Arugula 142 g 8 88048 00009 7 BEST BEFORE:2022 SE 062022 SE 072022 SE 082022 SE 132022 SE 142022 SE 15
Fresh Attitude Asian Mix 142 g 8 88048 00008 0 BEST BEFORE:2022 SE 082022 SE 102022 SE 132022 SE 15
Fresh Attitude Baby Spinach 142 g 8 88048 00004 2 BEST BEFORE:2022 SE 062022 SE 072022 SE 112022 SE 122022 SE 132022 SE 142022 SE 152022 SE 17
Fresh Attitude Duo Baby Kale And Spinach 142 g 8 88048 00304 3 BEST BEFORE:2022 SE 132022 SE 15
Fresh Attitude Half n’ Half Baby Spinach Spring Mix 142 g 8 88048 00034 9 BEST BEFORE:2022 SE 13
Fresh Attitude Hearty Harvest 142 g 8 88048 00011 0 BEST BEFORE:2022 SE 072022 SE 15
Fresh Attitude Kale Blend 142 g 8 88048 00010 3 BEST BEFORE:2022 SE 102022 SE 132022 SE 142022 SE 15
President’s Choice Baby Spinach 142 g 0 60383 22272 7 BEST BEFORE:2022 SE 052022 SE 132022 SE 15
President’s Choice Baby Spinach and Tender Red Lettuces 142 g 0 60383 00183 4 BEST BEFORE:2022 SE 062022 SE 102022 SE 15
President’s Choice Organics Arugula & Baby Spinach Salad mix 142 g 0 60383 19631 8 BEST BEFORE:2022 SE 052022 SE 062022 SE 072022 SE 102022 SE 112022 SE 142022 SE 15
President’s Choice Organics Baby Arugula 142 g 0 60383 99154 8 BEST BEFORE:2022 SE 052022 SE 062022 SE 07
President’s Choice Organics Baby Spinach 142 g 0 60383 99157 9 BEST BEFORE:2022 SE 052022 SE 072022 SE 082022 SE 092022 SE 14
President’s Choice Organics Field Greens & Baby Spinach Salad Mix 142 g 0 60383 19632 5 BEST BEFORE:2022 SE 15
President’s Choice Organics Field Greens Salad Mix 142 g 0 60383 99155 5 BEST BEFORE:2022 SE 15
President’s Choice Organics Kale, Chard & Spinach Salad Mix 142 g 0 60383 04753 5 BEST BEFORE:2022 SE 112022 SE 13
President’s Choice Spring Mix 142 g 0 60383 22274 1 BEST BEFORE:2022 SE 082022 SE 14
President’s Choice Sweet Baby Lettuces 142 g 0 60383 00184 1 BEST BEFORE:2022 SE 062022 SE 15
Fresh Attitude Arugula 142 g 8 88048 00009 7 BEST BEFORE:2022 SE 062022 SE 072022 SE 082022 SE 132022 SE 142022 SE 15
Fresh Attitude Asian Mix 142 g 8 88048 00008 0 BEST BEFORE:2022 SE 082022 SE 102022 SE 132022 SE 15
Fresh Attitude Baby Spinach 142 g 8 88048 00004 2 BEST BEFORE:2022 SE 062022 SE 072022 SE 112022 SE 122022 SE 132022 SE 142022 SE 152022 SE 17
Fresh Attitude Duo Baby Kale And Spinach 142 g 8 88048 00304 3 BEST BEFORE:2022 SE 132022 SE 15
Fresh Attitude Half n’ Half Baby Spinach Spring Mix 142 g 8 88048 00034 9 BEST BEFORE:2022 SE 13
Fresh Attitude Hearty Harvest 142 g 8 88048 00011 0 BEST BEFORE:2022 SE 072022 SE 15
Fresh Attitude Kale Blend 142 g 8 88048 00010 3 BEST BEFORE:2022 SE 102022 SE 132022 SE 142022 SE 15
Fresh Attitude Organic 50-50 Mix Baby Spinach-Spring Mix Spinach 142 g 8 88048 10011 7 BEST BEFORE:2022 SE 15
Fresh Attitude Organic Arugula 142 g 8 88048 10003 2 BEST BEFORE:2022 SE 052022 SE 062022 SE 072022 SE 102022 SE 122022 SE 15
Fresh Attitude Organic Baby Kale 142 g 8 88048 10005 6 BEST BEFORE:2022 SE 072022 SE 11
Fresh Attitude Organic Baby Spinach 142 g 8 88048 10001 8 BEST BEFORE:2022 SE 052022 SE 072022 SE 082022 SE 092022 SE 14
Fresh Attitude Organic Spring Mix 142 g 8 88048 10002 5 BEST BEFORE:2022 SE 15
Fresh Attitude San Marino Mix 142 g 8 88048 00007 3 BEST BEFORE:2022 SE 062022 SE 072022 SE 122022 SE 132022 SE 142022 SE 15
Fresh Attitude Spring Mix 142 g 8 88048 00003 5 BEST BEFORE:2022 SE 062022 SE 072022 SE 082022 SE 132022 SE 14
Compliments Baby Arugula 142 g 0 68820 12596 9 BEST BEFORE:2022 SE 082022 SE 112022 SE 132022 SE 15
Compliments Baby Spinach 142 g 0 68820 12597 6 BEST BEFORE:2022 SE 062022 SE 15
Compliments Spring Mix 142 g 0 68820 12598 3 BEST BEFORE:2022 SE 062022 SE 082022 SE 132022 SE 14

Consumers should not use, sell, serve or distribute the affected products.

(To sign up for a free subscription to Food Safety News, click here.)

Read More

Technology enables banks to identify riskless trade opportunities in turbulent markets

0
Technology enables banks to identify riskless trade opportunities in turbulent markets
#image_title

The need for data driven tools that enable riskless trading is vital in today’s market.
Read More

Bring a Trailer Clears $1 Billion in Car Sales So Far in 2022

0
Bring a Trailer Clears $1 Billion in Car Sales So Far in 2022
#image_title

The online auction platform has already surpassed last year’s total sales by capitalizing on a rising market for everything from Porsches to Pontiacs.
Read More

Britain’s Market Rout May Entice Foreign Bidders to UK Companies

0
Britain’s Market Rout May Entice Foreign Bidders to UK Companies
#image_title

A $300 billion rout for British stocks and a plunge in the pound is making UK companies even more attractive to foreign bidders, according to strategists.
Read More

‘Covid-19 vaccine administration must stop’ – Dr Aseem Malhotra’s MUST READ paper on mRNA vaccines

0
‘Covid-19 vaccine administration must stop’ – Dr Aseem Malhotra’s MUST READ paper on mRNA vaccines
#image_title

After the untimely cardiac death of his father, Dr Aseem Malhotra, a consultant cardiologist and an internationally renowned expert in the prevention, diagnosis and management of heart disease, who was one of the first to receive the double Pfizer Covid-19 mRNA vaccine in January 2021, started to thoroughly examine the real world data relating to mRNA vaccines. His examination culminated in a two-part paper titled ‘Curing the pandemic of misinformation on Covid-19 mRNA vaccines through real evidence-based medicine’, the public release of which was embargoed until late last night. The paper reveals glaring holes in the pivotal Pfizer mRNA trials and findings drawn from available pharmacovigilance data (as well as the absence of robust safety data), which led Dr Malhotra to describe the mRNA vaccine roll-out into the entire population as “a reckless gamble, at best”. Endorsed by many leading medical professionals, the paper emphasises that conversations in which the difference between the absolute and relative risk reduction afforded by the Covid-19 mRNA vaccines was explained to patients (a mere 0.84%, as suggested by the Pfizer mRNA trial) simply did not happen, not to mention the “known, unknown and as yet to be fully quantified harms”. Published in the Journal of Insulin Resistance, the paper has led to calls for the suspension of all Covid-19 vaccines. – Nadya Swart

‘Peer-reviewed papers in the Journal of Insulin Resistance present findings leading to calls for the suspension of all Covid-19 vaccines’

In a two-part paper titled “Curing the pandemic of misinformation on Covid-19 mRNA vaccines through real evidence-based medicine”, real world data reveals that in the non-elderly population the number needed to vaccinate to prevent one death from Covid-19 runs into thousands and that re-analysis of randomised controlled trial data suggests a greater risk of suffering a serious adverse event from the vaccine than of being hospitalised with Covid-19. 

Speaking about the report, Dr Malhotra said: 

  • “There has been a rise in out-of-hospital cardiac arrests and heart attacks linked to Pfizer’s Covid-19 mRNA vaccine, with plausible biological mechanisms of harm”
  • “Pharmacovigilance systems and real-world safety data, coupled with plausible mechanisms of harm, are deeply concerning, especially in relation to cardiovascular safety”

*See appendix below for reactions from the medical profession

2x Attachments (embedded below):

  • ‘Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine’ – Part 1 and Part 2

About Dr Malhotra

Dr Malhotra is a consultant cardiologist, Fellow of the Royal College of Physicians, and President of the Scientific Advisory Committee of The Public Health Collaboration. An internationally renowned expert in the prevention, diagnosis and management of heart disease, he is an honorary council member to the Metabolic Psychiatry Clinic at Stanford University School of Medicine, California.

APPENDIX

SUSPEND ALL COVID-19 MRNA VACCINES UNTIL SIDE EFFECTS (INCLUDING ADVERSE CARDIOVASCULAR OUTCOMES) ARE FULLY INVESTIGATED AND RELEASE RAW DATA, SAY LEADING DOCTORS

Doctor who promoted Covid-19 vaccine on TV calls for an immediate suspension to all Covid-19 vaccines to investigate serious side effects.

In new peer reviewed research, eminent consultant cardiologist Dr Aseem Malhotra exposes compelling evidence to suspend the roll out of all Covid-19 mRNA vaccines to investigate side effects and until all the raw data from clinical trials are released for independent scrutiny.

Recent re-analysis of Pfizer and Moderna randomised controlled trial data suggests the risk of suffering serious adverse effects of mRNA vaccines for individuals is significantly higher than the risk of being hospitalised with Covid-19.

There is a rise in out of hospital cardiac arrests and heart attacks linked to Pfizer’s Covid-19 mRNA vaccine, with a plausible biological mechanism of harm. 

The son of a leading GP claims the Covid-19 vaccine is a likely contributory factor in his father’s sudden cardiac death. The Journal of Insulin resistance paper gets widespread praise and support by leading doctors that include the President of the International Vascular Society Professor, Sherif Sultan, Jay Bhattacharya, Professor of Medicine at the University of Stanford, Clinical Advisor to the Royal College of General Practitioners Dr Campbell Murdoch and Chair of the West Pennine Local Medical Committee, General Practitioner, Dr Amir Hannan MBE. *see quotes from the medical profession in section below*

Leading doctors have supported calls to suspend all COVID-19 mRNA vaccines until serious side effects are fully investigated and the raw trial data from Pfizer’s covid -19 vaccine trial is released for independent analysis to help determine the true benefits and potential harms for different age groups. 

Writing in the peer-reviewed Journal of Insulin Resistance, one of the UK’s most eminent consultant cardiologists, Dr Aseem Malhotra, who was one of the first to take two doses of the vaccine and promote it on ITV’s Good Morning Britain (GMB), says that since the roll out of the vaccine the evidence of its effectiveness and true rates of adverse events have changed.

In a two part research paper entitled “Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine”, real world data reveals that in the non-elderly population the number needed to vaccinate to prevent one death from Covid-19 runs into thousands and that re-analysis of randomised controlled trial data (that first led to approval of the vaccines for BionTech/Pfizer and Moderna) suggests a greater risk of suffering a serious adverse event from the vaccine than of being hospitalised with Covid-19. 

Dr Malhotra writes, “Pharmacovigilance systems and real-world safety data, coupled with plausible mechanisms of harm, are sending deeply concerning signals, especially in relation to cardiovascular safety”.

Mirroring a potential signal from the Pfizer Phase 3 clinical trial, a significant rise in cardiac arrest calls to ambulances in England was seen in 2021 (an extra 14,000 compared to 2020) with similar data emerging from Israel in the 16–39-year-old age group where there was a 25% increase in heart attacks or cardiac arrests associated with the BionTech Pfizer vaccine administration but not associated with Covid-19. 

Citing the FDA’s own website, Dr Malhotra also highlights that testing positive for antibodies is an unreliable marker for immunity or protection against Covid after vaccination. He writes, “It cannot be said that the consent to receive these agents was fully informed, as is required ethically and legally,” and, “Authorities and sections of the medical profession have supported unethical, coercive, and misinformed policies such as vaccine mandates and vaccine passports, undermining the principles of informed consent. These regrettable actions are a symptom of the ‘medical misinformation mess’—the tip of a mortality iceberg where prescribed medications are estimated to be the third most common cause of death globally after heart disease and cancer.”

Underlying causes for this failure include regulatory capture. Guardians that are supposed to protect the public are in fact funded by the very corporations that stand to gain from the sale of those medications. A failure of public health messaging has also resulted in wanton waste of resources and a missed opportunity to help individuals lead healthier lives with relatively simple—and low cost—lifestyle changes. 

The unprecedented roll-out of an emergency use authorisation vaccine without access to the raw data, with increasing evidence of significant harms, compounded by mandates that appear to serve no purpose other than to bolster the profits of the drug industry, have highlighted modern medicine’s worst failings on an epic scale, with additional catastrophic harms to trust in public health.

There is a strong scientific, ethical and moral case to be made that the current COVID vaccine administration must stop until all the raw data has been subjected to fully independent scrutiny. Looking to the future, the medical and public health professionals must recognise these failings and eschew the tainted dollar of the medical-industrial complex. It will take a lot of time and effort to rebuild trust in these institutions, but the health of both humanity and the medical profession depend on it. 

Dr Malhotra concludes, “We must use this as an opportunity to transform the system to produce better doctors, better decision making, healthier patients and restore trust in medicine and public health. Until all the raw data on the mRNA COVID-19 vaccines have been independently analysed, any claims purporting that they confer a net benefit to humankind cannot be considered to be evidence-based.” 

REACTION FROM THE MEDICAL PROFESSION:

Sherif Sultan, Professor of Vascular Surgery and President of the International Vascular Society

“Doctor Aseem Malhotra’s literature review and analysis is a cause for global concern. We fully believe that vaccines are one of the great discoveries in medicine that has improved life expectancy dramatically. However, mRNA genetic vaccines are different, as long-term safety evaluation is lacking, but mandatory to ensure public safety. These findings raise concerns regarding vaccine-induced undetected severe cardiovascular side effects and underscore the established causal relationship between vaccines and myocarditis, a frequent cause of unexpected cardiac arrest in young individuals. Surveillance of potential vaccine side-effects and COVID-19 outcomes to identify public health trends and promptly investigate potential underlying causes needs immediate attention.” 

Jay Bhattacharya, Professor of Medicine and Epidemiology at the University of Stanford

“Dr Aseem Malhotra has written a detailed narrative review of the literature on the uses and abuses of the mRNA covid vaccines. Dr Malhotra makes a good case that there is considerable heterogeneity across age groups and other comorbid conditions in the expected benefits and expected side effect profiles of the vaccine. He finds that, while there may be a case for older people to take the vaccine because the benefits may outweigh expected harm, that may not be the case for younger people. Dr. Malhotra’s paper calls for a pause in the use of the vaccine in younger people, such as the one recently adopted by Danish public health authorities and the Florida department of public health in the United States.  He calls for investigation of side effect profiles of mRNA vaccines and for a halt to any vaccine mandate programs involving Covid vaccines. These papers should be considered carefully by all public health authorities who seek to adopt principles of evidence-based medicine in their recommendations to the public regarding the Covid mRNA vaccines.”

Dr Amir Hannan MBE, General Practitioner and Chairman of the West Pennine Local Medical Committee, Greater Manchester

“Dr Aseem Malhotra should be congratulated for putting this all together to help inform the public, the medical profession, the regulators, government, the pharmaceutical industry and wider society. Drug treatments and vaccinations can be an important part in helping to overcome disease and prevent illness, but we must remain vigilant against over reliance on the benefits and minimising or even suppressing the harms. Greater scrutiny of the data is needed and those overseeing medical practice to ensure the public and the profession remain safe. An urgent review is needed of the materials and information provided on the COVID-19 vaccines to help inform the public so that informed consent is gained through a shared decision-making process with education and training in light of the new evidence emerging.”

Dr Campbell Murdoch, General Practitioner and Clinical Advisor to the Royal College of General Practitioners

“Provision of safe and effective healthcare sits at the heart of medical services. As a GP, this is central to every action I take with patients. The healthcare regulator in England, the Care Quality Commission, requires this from all providers of medical care. As Dr Malhotra describes, to be able to provide safe and effective care, all healthcare professionals must practice evidence-based medicine. This is a combination of using the best available scientific evidence, the patient’s preferences, and the healthcare professional’s expertise. The combination of these three factors allows patients to make informed choices about what is best for their health. 

“In the case of the COVID-19 vaccination, Dr Malhotra describes multiple systemic failures in the provision of safe and effective evidence-based medicine. Consequently, it has been impossible for patients and the public to make an informed choice about what is best for their health and life.

“High quality healthcare requires organisations and individuals to act with complete integrity. Without this the delivery of safe and effective healthcare will always fail.

“Errors in healthcare can provide an opportunity to improve. It is now time to reflect and learn from the experience of the COVID-19 vaccination. Healthcare must always help, not harm.”

Dr Bob Gill, General Practitioner, activist and producer of the documentary The Great NHS Heist

“This important two-part review of the impact of the international roll-out of the mRNA vaccination program highlights significant concerns about the overstated benefits of vaccination especially in low-risk populations and the under-reporting of adverse events. Public information and consent to vaccination has not been balanced, neglecting discussion of individual risk versus benefit of having the shot. The quality of evidence provided by vaccine producers and lack of openness from the pharmaceutical industry risk longlasting damage to confidence in public health interventions. 

Part Two of the review sets out how regulatory capture by pharmaceutical corporations and their immense financial power influences politicians and media to promote products at the expense of scientific scrutiny and unfettered access to research on which decisions of immense impact are made. Bias and conflicts of interest abound in the medical-industrial complex with well documented adverse outcomes for patients from over medicalisation and prescription drugs. Coercive vaccine mandates based on biased and short trials with unpublished raw data is the culmination of the unchecked power of the pharmaceutical industry to the exclusion of effective lifestyle factor risk reduction which was ignored by media and politicians alike.  

Given the declining virulence of the infection and mounting evidence of vaccine-related harms, there can be no justification to continued mass roll-out of booster programs given that the short-term risks from the vaccine likely outweigh the benefits for the majority of the population, and we remain ignorant of the long-term risk to health.”

Dr Renee Hoenderkamp, General Practitioner, writer and broadcaster

“This is an important paper from Aseem. As a GP in a small practice, I have two young patients with post vaccine heart conditions confirmed. They were not counselled on the risk of this as part of an informed consent process. Surely any medical professionals should want their patients to fully understand the risks and benefits of a medication they take, and welcome that discussion? As the evidence evolves and we see clearly that the risk from both Covid-19 and the vaccine designed to protect against it differs massively by age, sex, co-morbidity, and previous infection, it becomes ever more important to give patients the information they need to make an informed decision. This important paper brings those risks and benefits into sharp focus and should allow the desperately needed discussion that has thus far been sorely missing from any examination of vaccination benefits and harms. Aseem opens up the discussion around both the harms and the ability to have a healthy discourse and I welcome it.” 

About The Journal of Insulin Resistance

The Journal of Insulin Resistance is a peer-reviewed, clinically oriented open access journal covering advances in disorders related to insulin resistance. Articles will focus on pathophysiology, prevention, management and advancing therapy for different patient populations with insulin resistance and related disorders, including obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, nonalcoholic steato-hepatitis, Alzheimer’s dementia, and sexual dysfunction, amongst others. The journal will feature original research with a broad biomedical approach from bench to bedside, including basic research and clinical case studies, as well as review articles and editorials. Content will be of interest to an academic and clinician-based audience, ie medical practitioners, clinical educators, dietitians, nutritionists, nurse practitioners, pharmacists, and other health care professionals. Submissions in English (full article) will be considered for publication.

Read Also:

  • Meet Dr Jackie Stone, the ‘rogue’ doctor being punished for eradicating Covid-19 in Zimbabwe
  • The original fake medical news story – Prof Noakes on Ancel Keys’ Cholesterol Con
  • ‘We can no longer trust science at all’ – Dr Peter Breggin on Fauci, Covid-19 and the global predators profiting from vaccines

(Visited 6,947 times, 6,947 visits today)

Read More

Vodacom leads the charge to private power generation, away from Eskom

0
Vodacom leads the charge to private power generation, away from Eskom
#image_title

The effects of Eskom’s shortfalls have caused rampant loadshedding, which is not only expensive and unbelievably frustrating for South Africans, but also unbelievably economically damaging, with R4bn wiped from the South African GDP for each day of stage 6 cuts. Many companies run generators to ensure they can be productive under rolling blackouts, but companies with far-spread infrastructure struggle in these conditions. Now that independent power producers are allowed to operate in South Africa to make up for the severe lack of power provided by Eskom, companies like Vodacom are leading the way to ensure independent power producers supply all their infrastructure. More in this article from MyBroadband. – Ross Sinclair 

Goodbye, Eskom — Vodacom to pilot buying all its power from independent producers

By Jan Vermeulen

Vodacom South Africa says it will soon launch a pilot with Eskom to source all its electricity from renewable independent power producers.

It said the pilot’s success would provide Vodacom with renewable power and a blueprint for other South African corporates to replicate.

This would let more companies add capacity to the grid and help solve South Africa’s energy crisis, stated Vodacom.

Vodacom said its operating situation is unique due to the complexities of having over 15,000 distributed low-voltage sites across the country with linkage to 168 municipalities.

Until now, this complexity has prevented Vodacom from accessing power purchase agreements and “wheeling” — or transferring energy over Eskom’s grid.

While Vodacom would get its electricity from non-Eskom sources if the pilot is successful, the state-owned power utility would still provide transmission infrastructure and services.

“They want to start their own green power generation for their towers, but how do they get the electricity to the towers? That is where we will come in,” Eskom CEO André De Ruyter said in a wide-ranging Sunday Times interview.

De Ruyter explained that although Eskom is executing a plan to rent out land on which private power producers can build renewable energy generation, this takes time that South Africa simply does not have.

He said that Vodacom’s initiative is part of the government’s and Eskom’s shorter-term plans to unlock essential additional electricity generating capacity from South Africa’s private sector.

Eskom calls its appeal to the private sector “100 megawatts from 100 companies”.

If a hundred of South Africa’s large corporations could each put 100MW onto the grid, that would be 10,000MW — equivalent to 10 stages of load-shedding.

Vodacom said it is in the last phase of the commercial processes to secure power purchase agreements with independent power producers.

However, it cautioned that the project would not directly improve energy security at its sites.

According to Vodacom, access to renewable power benefits customers by reducing the carbon footprint of the country’s energy sector and promoting access to cost-effective, sustainable energy sources.

The pilot’s success would also enable other companies to access renewable power purchase agreements, allowing the private sector to assist Eskom with much-needed additional capacity.

“This is a monumental move forward to assist Eskom and South Africa to solve the energy crisis, which proves our greatest threat to an economic recovery,” said Vodacom Group CEO Shameel Joosub.

“It is our belief that the energy crisis in South Africa can be solved with the assistance of private sector participation and enablement — this solution does just that, and can be fast-tracked and scaled to address the shortfall of generation capacity within two years.”

Joosub said access to reliable and low-cost energy is fundamental for any modern economy to flourish.

“Through Vodacom’s partnership with Eskom, we will be able to meet our 2025 commitments to source 100% of our electricity from renewable sources across all our operations.”

South Africa’s cellular carriers have struggled to keep their mobile networks operational during the higher levels of load-shedding this past week.

While stage 6 load-shedding raged, Vodacom warned that if power cuts continued, it could cause total network blackouts in some areas.

The operator’s statements to the press came after South Africans complained of degraded network performance and intermittent connectivity in some places.

Although South Africa’s mobile network operators have battery backups at a substantial proportion of their towers, higher stages of load-shedding prevent the batteries from recharging fully.

MTN corporate affairs executive Jacqui O’Sullivan reiterated last week that their batteries need much more time to recharge than load-shedding schedules allowed.

“The problem is that the batteries need 12 to 18 hours to recharge,” O’Sullivan said.

“They give you 6 to 12 hours of capacity depending on the site.”

“The key thing is that during stage 5 and stage 6, there isn’t 12 to 18 hours between load-shedding to allow those batteries to recharge.”

To combat this problem, Vodacom and MTN have deployed “backups for the backup”, using thousands of mobile generators around the country to power sites and recharge batteries at critical towers.

O’Sullivan said that MTN burns roughly 450,000 litres of fuel per month during stage 5 and stage 6 power cuts.

Vodacom said it had spent around R2 billion just on batteries over the past two years.

Just over a year ago, Vodacom unveiled three new solar-powered sites in Polokwane, Vereeniging and Bloemfontein.

Vodacom spent R8 million on the sites, which annually generate approximately 127MWh.

In 2019, Vodacom unveiled a solar photovoltaic system at its Randburg base station controller in Johannesburg that can generate 34kW of power.

“In the past, we’ve installed solar panels at Vodacom offices as well as in our network infrastructure, however using solar energy to power our base station controllers is an area of opportunity for us,” Vodacom SA external affairs director Takalani Netshitenzhe said at the time.

Read also:

  • What will happen if Eskom has to implement Stage 8 loadshedding?
  • ANC greed results in failing municipalities
  • Everything else is privately supplied – now you can add your power

(Visited 1,438 times, 1,438 visits today)

Read More

Watch Colorado Rockies at San Francisco Giants: Stream MLB live

0
Watch Colorado Rockies at San Francisco Giants: Stream MLB live
#image_title

The Colorado Rockies travel to San Francisco on Tuesday to play the Giants for the last time this season.

Baseball is back on Tuesday after much of the league got the day off on Monday. That includes action between the Colorado Rockies and San Francisco Giants. This is the last time these National League West rivals will play each other this season. 

The Giants (75-78) are 11-5 so far against Colorado this season. The Rockies are trying to finish above 70 games, but they are five away with a tough schedule remaining against the Giants and Dodgers all on the road. 

How to Watch Colorado Rockies at San Francisco Giants Today:

Game Date: Sept. 27, 2022

Game Time:  9:45 p.m. ET

TV Channel: NBC Sports Bay Area

Live stream Colorado Rockies at San Francisco Giants on fuboTV: Start your free trial today!

Colorado finished its last home series against the Padres over the weekend dropping two of three games. In the series before that the Rockies got swept in a four-game series against the Giants. The Rockies were trying to climb back from an early deficit in their last game, but the Padres offense was too much. Led by back-to-back homers by Manny Machado and Brandon Drury, the Padres scored five in the eighth inning to easily put the game away winning 13-6. 

The Giants meanwhile won 3-2 on a go-ahead, two-RBI single in a pinch-hit appearance in the eighth inning. San Francisco has now won six of its last seven. The Giants will try to keep it rolling tonight by starting Logan Webb, who is 14-9 with a 2.93 ERA. The Rockies will counter in the opener with German Marquez, who is 8-12 with a 5.15 ERA. 

Regional restrictions may apply.

On: NBC Sports Bay Area

Colorado Rockies at San Francisco Giants

Start your free trial today

Sports Illustrated may receive compensation for some links to products and services on this website.

Read More